To achieve our goal of expanding MR spectroscopy to other disciplines, we have established multiple collaborations across departments and with almost all Harvard institutions. This work includes improved diagnostics for brain cancer with BWH Neuro-oncology and Dana-Farber Cancer Institute, measuring treatment effects in the liver with the Joslin Diabetes Center, biomarkers for metabolic disorders with Boston Children’s Hospital, HIV research with Massachusetts General Hospital, and schizophrenia with Harvard Medical School and Veterans Administration Boston. Our research portfolio is diversified across multiple disciplines and we received funding from NIH, DOD, and through several industry agreements and awards. We continue close collaboration with industry leaders such as General Electric Healthcare and Siemens Healthcare.